{"id":17866,"date":"2014-04-09T13:30:00","date_gmt":"2014-04-09T11:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/intervista-a-miceli-filctem-il-capitale-del-pharma-sono-le-sue-qualificate-risorse-umane\/"},"modified":"2014-04-09T13:30:00","modified_gmt":"2014-04-09T11:30:00","slug":"intervista-a-miceli-filctem-il-capitale-del-pharma-sono-le-sue-qualificate-risorse-umane","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/intervista-a-miceli-filctem-il-capitale-del-pharma-sono-le-sue-qualificate-risorse-umane\/","title":{"rendered":"Interview with Miceli (Filctem). The capital of Pharma is its qualified human resources"},"content":{"rendered":"<p class=\"MsoNormal\" style=\"text-align: left; line-height: 13.5pt; margin: 0cm 0cm 0pt\"><font face=\"Calibri\"><span style=\"font-family: OpenSansLightRegular; color: #666666; font-size: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: IT; mso-bidi-font-family: 'Times New Roman'\">venerd&igrave; 4 aprile 2014<span style=\"mso-spacerun: yes\">&nbsp; <\/span><\/span><span lang=\"EN\" style=\"font-family: OpenSansLightRegular; color: #666666; font-size: 9pt; mso-ansi-language: EN\"><a title=\"HPS\" href=\"http:\/\/www.aboutpharma.com\/hps\/\" target=\"_blank\" rel=\"noopener\"><span lang=\"IT\" style=\"mso-ansi-language: IT\"><font color=\"#333333\">about HPS<\/font><\/span><\/a>&nbsp;&nbsp;&nbsp;&nbsp; <img decoding=\"async\" class=\"rg_i\" name=\"s4U5YH6ogKZ16M:\" alt=\"\" data-src=\"https:\/\/encrypted-tbn1.gstatic.com\/images?q=tbn:ANd9GcRv1P34y1YGdw8RS7bNA-I0OJnAniRZH1zCJBKJBRnv_JzpaXVX\" data-sz=\"f\" style=\"margin-top: 0px; width: 109px; height: 14px; margin-left: 0px; margin-right: 0px\" src=\"https:\/\/encrypted-tbn1.gstatic.com\/images?q=tbn:ANd9GcRv1P34y1YGdw8RS7bNA-I0OJnAniRZH1zCJBKJBRnv_JzpaXVX\" \/><\/span><span style=\"font-family: OpenSansLightRegular; color: #595959; font-size: 10.5pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: IT; mso-bidi-font-family: 'Times New Roman'\"><\/p>\n<p><\/span><\/font><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; line-height: 13.5pt; margin: 0cm 0cm 10pt\"><font face=\"Calibri\"><span style=\"font-family: OpenSansLightRegular; color: #595959; font-size: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: IT; mso-bidi-font-family: 'Times New Roman'\">Of <\/span><b><span style=\"font-family: OpenSansLightRegular; color: #333333; font-size: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: IT; mso-bidi-font-family: 'Times New Roman'\">Editorial board <\/span><\/b><span style=\"font-family: OpenSansLightRegular; color: #595959; font-size: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: IT; mso-bidi-font-family: 'Times New Roman'\"><\/p>\n<p><\/span><\/font><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; margin: 0cm 0cm 15pt; mso-line-height-alt: 13.5pt; mso-outline-level: 2\"><span style=\"font-family: OpenSansLightRegular; font-size: 15pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: IT; mso-bidi-font-family: 'Times New Roman'\"><font face=\"Calibri\">Intervista a Emilio Miceli, segretario generale della Filctem Cgil<\/p>\n<p><\/font><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; line-height: 13.5pt; margin: 7.5pt 0cm\"><span lang=\"EN\" style=\"font-family: OpenSansLightRegular; color: #595959; font-size: 10.5pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: IT; mso-bidi-font-family: 'Times New Roman'; mso-ansi-language: EN\"><a target=\"_blank\" href=\"http:\/\/www.aboutpharma.com\/in-edicola\/riviste\/aboutpharma\/aboutpharma-and-medical-devices-n-117\/\" rel=\"noopener\"><b><u><span lang=\"IT\" style=\"color: #2c6995; mso-ansi-language: IT\"><font face=\"Calibri\">Dal numero 117 di Aboutpharma and Medical Devices di aprile<\/font><\/span><\/u><\/b><\/a><\/span><span style=\"font-family: OpenSansLightRegular; color: #595959; font-size: 10.5pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: IT; mso-bidi-font-family: 'Times New Roman'\"><\/p>\n<p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; line-height: 13.5pt; margin: 7.5pt 0cm 12pt\"><span style=\"font-family: OpenSansLightRegular; font-size: 12pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: IT; mso-bidi-font-family: 'Times New Roman'\"><font face=\"Calibri\">Il dialogo c&rsquo;&egrave;, la condivisione dei problemi pure ma cercando le soluzioni <b>non si possono abbandonare per strada i qualificati lavoratori del Pharma<\/b>. Altri percorsi sono da battere: principalmente ridurre il costo dell&rsquo;energia per consentire anche in Italia il decollo di politiche attrattive che consentano all&rsquo;industria di fare il suo mestiere.<br \/> Lo pensa <b>Emilio Miceli, palermitano, classe &#038;r<\/p>","protected":false},"excerpt":{"rendered":"<p>venerd&igrave; 4 aprile 2014&nbsp; about HPS&nbsp;&nbsp;&nbsp;&nbsp; di Redazione Intervista a Emilio Miceli, segretario generale della Filctem Cgil Dal numero 117 di Aboutpharma and Medical Devices di aprile Il dialogo c&rsquo;&egrave;, la condivisione dei problemi pure ma cercando le soluzioni non si possono abbandonare per strada i qualificati lavoratori del Pharma. Altri percorsi sono da battere: &hellip;<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-17866","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/17866","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=17866"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/17866\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=17866"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=17866"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=17866"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}